Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use
Author:
Affiliation:
1. University of Sydney, Sydney, NSW, Australia
2. NSW Health Pathology, Sydney, NSW, Australia
3. Western Sydney Local Health District, Westmead, NSW, Australia
Funder
NSW Ministry of Health
Publisher
Massachusetts Medical Society
Subject
General Medicine
Link
http://www.nejm.org/doi/pdf/10.1056/NEJMc2120219
Reference3 articles.
1. Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab
2. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
3. Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
Cited by 150 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Amidino-rocaglates (ADRs), a class of synthetic rocaglates, are potent inhibitors of SARS-CoV-2 replication through inhibition of viral protein synthesis;Antiviral Research;2024-10
2. Respiratory syncytial virus infections in adults: a narrative review;The Lancet Respiratory Medicine;2024-09
3. Immune and inflammation features of severe and critical Omicron infected patients during Omicron wave in China;BMC Infectious Diseases;2024-08-09
4. Ronapreve (REGN-CoV; casirivimab and imdevimab) reduces the viral burden and alters the pulmonary response to the SARS-CoV-2 Delta variant (B.1.617.2) in K18-hACE2 mice using an experimental design reflective of a treatment use case;Microbiology Spectrum;2024-08-06
5. Protective non-neutralizing SARS-CoV-2 monoclonal antibodies;Trends in Immunology;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3